CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.50
-0.14 (-1.46%)
Nov 21, 2024, 12:59 PM EST - Market open
CervoMed Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 78 | 43 | - | - |
| Enterprise Value | 33 | 33 | - | - |
| Last Close Price | 9.64 | 7.63 | - | - |
| PS Ratio | 7.15 | 6.06 | - | - |
| PB Ratio | 1.74 | 5.87 | - | - |
| P/TBV Ratio | 2.64 | 5.87 | - | - |
| EV/Sales Ratio | 3.27 | 4.60 | - | - |
| Debt / Equity Ratio | - | - | -1.38 | -2.74 |
| Asset Turnover | 0.33 | 1.01 | - | - |
| Quick Ratio | 14.45 | 3.35 | 0.31 | 1.48 |
| Current Ratio | 15.04 | 3.84 | 0.32 | 1.50 |
| Return on Assets (ROA) | -25.99% | -62.04% | -39.59% | - |
| Return on Capital (ROIC) | -28.68% | -81.22% | -44.40% | - |
| Earnings Yield | -15.02% | -5.02% | - | - |
| FCF Yield | -13.85% | -17.21% | - | - |
| Buyback Yield / Dilution | -510.12% | -413.65% | 88.49% | - |
| Total Shareholder Return | -510.12% | -413.65% | 88.49% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.